Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
BSS (Balanced Salt Solution) is an irrigation solution administered via intraocular route, used to maintain anterior chamber stability during ophthalmic surgery and to treat conditions including glaucoma, diabetic retinopathy, and vitreomacular adhesion. It is a small-molecule formulation with no active pharmacologic mechanism of action, functioning primarily as a physiologic irrigant to maintain ocular tissue integrity.
Product is in late-stage lifecycle with minimal Part D penetration (198 claims in 2023), indicating a mature, niche formulaic product with limited commercial growth potential and likely small dedicated team.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
The Evaluation of Balanced Salt Solution During Cataract Surgery
Spinal Cord Stimulation Versus Instrumentation for FBSS
First in Human Study of a Monoclonal Antibody (SOL-116) Targeting BSSL (Bile Salt-Stimulated Lipase), Single and Multiple Dose Parts
Hospital Avoidance Strategies for ABSSSI
A Study of IMR-687 in Adult Participants With Sickle Cell Anemia (Homozygous HbSS or Sickle-β0 Thalassemia)
Worked on BSS at Alcon? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moBSS has zero linked job openings and occupies a mature, non-growing formulaic niche with minimal Part D claims (198 in 2023) and significant competitive pressure from high-spending active-mechanism alternatives. Career opportunities are limited to specialized roles in formulary management, compliance, or small-scale field operations rather than strategic growth positions.